Popescu-Hobeanu Gabriela, Cucu Mihai-Gabriel, Calotă-Dobrescu Alexandru, Dragotă Luminița, Riza Anca-Lelia, Streață Ioana, Pleșea Răzvan Mihail, Pătru Ciprian Laurențiu, Comănescu Cristina Maria, Tudorache Ștefania, Iliescu Dominic, Burada Florin
Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Laboratory of Human Genomics, University of Medicine and Pharmacy of Craiova, 200638 Craiova, Romania.
Genes (Basel). 2025 Jul 24;16(8):867. doi: 10.3390/genes16080867.
: Miscarriage is an increasingly common event worldwide arising from various factors, and identifying its etiology is important for planning and managing any future pregnancies. It is estimated that about half of early pregnancy loss cases are caused by genetic abnormalities, while a significantly lower rate is found in late pregnancy loss. Multiplex ligation-dependent probe amplification (MLPA) can detect small changes within a gene with precise breakpoints at the level of a single exon. The aim of our study was to identify the rate of copy number variations (CNVs) in spontaneous pregnancy loss samples after having previously tested them via quantitative fluorescence PCR (QF-PCR), with no abnormal findings. : DNA was extracted from product-of-conception tissue samples, followed by the use of an MLPA kit for the detection of 31 microdeletion/microduplication syndromes (SALSA MLPA Probemix P245 Microdeletion Syndromes-1A, MRC-Holland, Amsterdam, The Netherlands). : A total of 11 (13.1%) out of the 84 successfully tested samples showed CNVs. Duplications accounted for 9.5% of the analyzed samples (eight cases), while heterozygous or hemizygous deletions were present in three cases (3.6%). Among all the detected CNVs, only three were certainly pathogenic (3.6%), with two deletions associated with DiGeorge-2 syndrome and Rett syndrome, respectively, and a 2q23.1 microduplication syndrome, all detected in early pregnancy loss samples. For the remaining cases, additional genetic tests (e.g., aCGH/SNP microarray) are required to establish CNV size and gene content and therefore their pathogenicity. : MLPA assays seem to have limited value in detecting supplementary chromosomal abnormalities in miscarriages.
流产在全球范围内是一种因各种因素导致的日益常见的事件,确定其病因对于规划和管理未来的妊娠至关重要。据估计,约一半的早期妊娠丢失病例是由基因异常引起的,而晚期妊娠丢失的发生率则显著较低。多重连接依赖探针扩增(MLPA)可以在单个外显子水平上检测基因内具有精确断点的微小变化。我们研究的目的是在先前通过定量荧光PCR(QF-PCR)对自然流产样本进行检测且未发现异常结果后,确定拷贝数变异(CNV)的发生率。从妊娠产物组织样本中提取DNA,随后使用MLPA试剂盒检测31种微缺失/微重复综合征(SALSA MLPA Probemix P245微缺失综合征-1A,MRC-Holland,荷兰阿姆斯特丹)。在84个成功检测的样本中,共有11个(13.1%)显示出CNV。重复占分析样本的9.5%(8例),杂合或半合子缺失存在于3例(3.6%)中。在所有检测到的CNV中,只有3个肯定是致病性的(3.6%),其中2个缺失分别与迪乔治-2综合征和雷特综合征相关,还有一个2q23.1微重复综合征,均在早期妊娠丢失样本中检测到。对于其余病例,需要进行额外的基因检测(如aCGH/SNP微阵列)以确定CNV的大小和基因内容,从而确定其致病性。MLPA检测在检测流产中额外的染色体异常方面似乎价值有限。